Neuronetics Announces Lisa Metzner-Rosas as SVP, Chief Marketing Officer
01 mai 2023 08h46 HE
|
Neuronetics
MALVERN, Pa., May 01, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Announces Expanded TMS Access through United HealthCare
28 avr. 2023 16h11 HE
|
Neuronetics
MALVERN, Pa., April 28, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics to Report First Quarter 2023 Financial and Operating Results and Host Conference Call
25 avr. 2023 08h30 HE
|
Neuronetics
MALVERN, Pa., April 25, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Announces Continued Momentum for Expanded Health Insurance Coverage for TMS Therapy
13 avr. 2023 08h58 HE
|
Neuronetics
MALVERN, Pa., April 13, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
NeuroStar® Advanced Therapy Enhanced With Wi-Fi Capabilities
06 avr. 2023 16h16 HE
|
Neuronetics
MALVERN, Pa., April 06, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Secures Up To $60 Million in New Debt Financing with SLR Capital Partners, Provides Greenbrook TMS with $6.0 Million Promissory Note
04 avr. 2023 08h30 HE
|
Neuronetics
MALVERN, Pa., April 04, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients...
NeuroStar® Advanced Therapy Receives Patient Impact Award from Life Sciences PA
16 mars 2023 08h56 HE
|
Neuronetics
MALVERN, Pa., March 16, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Reports Record Fourth Quarter and Record Full Year 2022 Financial and Operating Results
07 mars 2023 07h30 HE
|
Neuronetics
MALVERN, Pa., March 07, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients...
Neuronetics Announces TMS Coverage Criteria Changes for Over 23 Million Covered Lives
02 mars 2023 16h02 HE
|
Neuronetics
MALVERN, Pa., March 02, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
27 févr. 2023 16h30 HE
|
Neuronetics
MALVERN, Pa., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...